Mekinist (Trametinib) Tablets
Generic name : Trametinib.
Trade name : Mekinist.
Manufacturer information :
Mekinist is manufactured by GlaxoSmithKline.
Mekinist FDA Approval :
Mekinist first approved May 29th, 2013.
Mekinist Dosage form :
Tablets: 0.5 mg, 1 mg, and 2 mg.
Mekinist Indications and Usage :
MEK inhibitor indicated as a single agent or in combination with dabrafenib for unresectable or metastatic melanoma with BRAF V600E or V600K mutations.
Mekinist (Trametinib) availability in India
- You could import this medicine against import permit on Patient Name.
- Please contact ACT Lifesciences Private Limited for further information.